West Pharmaceutical Services Inc (NYSE:WST)
| 296.72 Delayed Data As of 3:59pm ET |  +0.20 / +0.07%Today’s Change | 156.92 Today|||52-Week Range 312.12 | +4.73% Year-to-Date |
Latest WST News | Press Releases
No recent news for West Pharmaceutical Services Inc.
Today’s Trading
| Previous close | 296.52 |
| Today’s open | 295.73 |
| Day’s range | 295.24 - 298.58 |
| Volume | 334,724 |
| Average volume (3 months) | 472,727 |
| Market cap | $21.9B |
Data as of 3:59pm ET, 04/12/2021
Growth & Valuation
| Earnings growth (last year) | +43.43% |
| Earnings growth (this year) | +29.31% |
| Earnings growth (next 5 years) | +18.81% |
| Revenue growth (last year) | +16.44% |
| P/E ratio | 65.0 |
| Price/Sales | 10.00 |
| Price/Book | 11.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | -0.80 | -0.19% |
| PODDInsulet Corp | -2.01 | -0.70% |
| ABMDABIOMED Inc | -0.36 | -0.11% |
| PENPenumbra Inc | -6.04 | -2.22% |
Data as of 3:59pm ET, 04/12/2021
Financials
| Next reporting date | April 29, 2021 |
| EPS forecast (this quarter) | $1.43 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $346.2M |
| Net profit margin | 16.13% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Exton, Pennsylvania |
Forecasts
